Depo Provera: The Food and Drug Administration approved a label change on Friday for Pfizer’s birth control injection, Depo-Provera, alerting patients to the risk of meningioma, a tumor that develops ...

Recent scientific research has revealed that women who used the Depo-Provera birth control shot may be five times more likely to develop a form of brain tumors known as meningioma. Women who were ...

Meningioma brain tumors are often described as slow-growing and benign. But for many patients, the effects are anything but minor. These tumors can press on critical areas of the brain, leading to ...

Depo Provera Brain Tumor: Medroxyprogesterone acetate, a contraceptive injection containing the hormone progestin, is widely known by its brand name, Depo-Provera. Administered every three months, it ...

The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients to a possible risk for a type of brain ...

Drugwatch has provided people injured by harmful drugs and devices with reliable answers and experienced legal help since 2009. Brought to you by The Wilson Firm LLP, we've pursued justice for more ...

Pfizer Inc. (NYSE: PFE) faces mounting legal challenges over claims that its contraceptive injection Depo-Provera (DMPA) is linked to brain tumors, with a key court hearing set for late September that ...

Pfizer (NYSE:PFE) is facing an increasing number of lawsuits in the U.S. over its alleged failure to warn that its Depo-Provera contraceptive injection for women can cause a brain tumor called ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Contraception is often used to prevent pregnancies and manage menstrual ...

This content is for informational purposes only and is not intended to provide legal advice. Depo-Provera is a birth control shot used by millions to prevent pregnancy. While it is effective and ...

The choice of safe and highly effective contraception for women who have special medical conditions can pose tremendous challenges. Viral hepatitis such as hepatitis C virus (HCV) is a major public ...

The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...